| 高血压大鼠足细胞的超微病变和podocalyxin的表达及其作用研究 |
| 投稿时间：2011-03-28 修订日期：2011-03-30 点此下载全文 |
| 引用本文：刘以鹏,刘淑华,李婷,朱刚艳,黄红春.高血压大鼠足细胞的超微病变和podocalyxin的表达及其作用研究[J].医学研究杂志,2011,40(11):63-66 |
| DOI：
|
| 摘要点击次数: 1225 |
| 全文下载次数: 998 |
|
| 基金项目:湖北省卫生厅科研课题（JX4C22） |
|
| 中文摘要:目的观察高血压大鼠足细胞的超微结构病变，探讨足细胞蛋白podocalyxin（PCX）在高血压大鼠肾组织中的表达及作用。 方法随机将30只雄性SD大鼠以改进的 “两肾一夹” 方法建立高血压大鼠模型，分为高血压组和对照组。分别于造模前和造模后1、5、10周检测两组大鼠的尿β2-微球蛋白 (β2-MG)、血尿素氮（BUN）及血肌酐（Scr）水平；免疫荧光方法观察PCX在肾组织的表达，并用Image-pro plus 6.0软件，以面积密度值进行分析；光镜、电镜观察肾小球及足细胞超微结构改变。 结果（1）术后2周起高血压组收缩压(SBP)较对照组显著升高(137.2±9.4mmHg vs 92.3±10.3mmHg，P<0.01),并且逐渐升高至术后4周趋于平稳。（2）术后5周起高血压组尿β2-MG显著高于对照组［(110.28±11.25)ng/L vs (56.68±951)ng/L,P<0.01］，并且有继续增高的趋势。两组BUN、Scr在整个实验过程中没有显著性差异。（3）光镜、电镜观察均可见高血压组肾脏发生病理改变；足细胞超微结构发生病变。（4）免疫荧光可见高血压组PCX表达明显减少，其面积密度值显著低于对照组(0.204±0.042 vs 0.296±0.039，P＜0.01)，且PCX表达与尿β2-MG呈显著负相关（r=-0.927，P＜0.01）。 结论PCX蛋白表达降低可能是参与高血压肾损害的机制之一，其可能是导致肾小球电荷屏障受损、尿蛋白排泄增加、肾功能受损、肾脏病理及足细胞超微结构发生病变的基础之一。 |
| 中文关键词:高血压肾损害 足细胞 超微病变 Podocalyxin |
| |
| PodocalyxinUltrastructure Pathological Changes of Podocyte and the Expression of Podocalyxin in the Kidney of Hypertensive Rats |
|
|
| Abstract:ObjectiveTo observe the ultrastructure pathological changes of podocyte and to investigate the expression and roles of the podocyte-associated molecule podocalyxin(PCX) in the kidney of 2-kidney-1-clip hypertensive rats. MethodsThirty male SD rats were randomly assigned into two groups: experimental group(n=20)and control group(n=10). Improved 2-kidney-1-clip hypertensive rats were used in the experiment. The urinary β2-microglobulin(β2-MG), blood urea nitrogen(BUN) and serum creatinine(Scr) were monitored at different stages. The expression of podocalyxin in the kidney was detected by using immunofluorescence, and analyzed by Image-pro plus 6.0 software. The pathological changes of the kidney and podocyte were observed under optical and electron microscope respectively. ResultsThe systolic blood pressure 2 weeks after operation in experimental group was significantly higher than that in control group (P<0.01). The urinary β2-MG 5 weeks after operation in experimental group was significantly higher than in that control group (P<0.01), but the BUN and Scr levels in experimental group had no significant difference compared with control group in the whole process. We could see pathological changes of the kidney under optical and electron microscope. The expression of PCX in experimental group was significantly lower than in control group(P<0.01), and it was negatively correlated with the urinary β2-MG(r=-0.927, P<0.01). ConclusionThe reduction of the expression of the podocyte-associated molecule podocalyxin may be one of the pathogenesises of hypertensive kidney lesion. It may lead to injury of charge barrier in glomerulus, the increase of the excretion of urinary β2-MG, and impairment of renal function. |
| keywords:Hypertensive renal disease Podocyte Ultrastructure pathological changes Podocalyxin |
| 查看全文 查看/发表评论 下载PDF阅读器 |
